Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

But it's not all there.

Peterson JD, Bilyk JR, Sergott RC.

Surv Ophthalmol. 2013 Sep-Oct;58(5):492-9. doi: 10.1016/j.survophthal.2012.02.009. Epub 2012 Jul 10.

PMID:
22784676
2.

False-negative apraclonidine testing in acute Horner syndrome.

Dewan MA, Harrison AR, Lee MS.

Can J Ophthalmol. 2009 Feb;44(1):109-10. doi: 10.3129/i08-162. No abstract available.

PMID:
19169332
3.

Topical apraclonidine in the diagnosis of suspected Horner syndrome.

Freedman KA, Brown SM.

J Neuroophthalmol. 2005 Jun;25(2):83-5.

PMID:
15937427
4.

Early diagnosis of Horner syndrome using topical apraclonidine.

Cooper-Knock J, Pepper I, Hodgson T, Sharrack B.

J Neuroophthalmol. 2011 Sep;31(3):214-6. doi: 10.1097/WNO.0b013e31821a91fe.

PMID:
21566530
5.

Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?

Kardon R.

J Neuroophthalmol. 2005 Jun;25(2):69-70. No abstract available.

PMID:
15937425
6.

[Usefulness of apraclonidine in the diagnosis of Horner syndrome].

Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM.

Arch Soc Esp Oftalmol. 2009 Feb;84(2):105-8. Spanish.

7.

Possible effect of systemic sympathicolytic drugs on apraclonidine test.

Martín-Moro JG, Botín DM, Muñoz-Negrete FJ.

Can J Ophthalmol. 2009 Aug;44(4):463; author reply 463-4. doi: 10.3129/i09-124. No abstract available.

PMID:
19606173
8.

Brief, transient Horner's syndrome can be the hallmark of a carotid artery dissection.

Leira EC, Bendixen BH, Kardon RH, Adams HP Jr.

Neurology. 1998 Jan;50(1):289-90.

PMID:
9443497
9.

[Acquired Horner's syndrome].

Alstadhaug KB.

Tidsskr Nor Laegeforen. 2011 May 20;131(9-10):950-4. doi: 10.4045/tidsskr.10.0935. Review. Norwegian.

10.

Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.

Lebas M, Seror J, Debroucker T.

J Neuroophthalmol. 2010 Mar;30(1):12-7. doi: 10.1097/WNO.0b013e3181b1b41f. Review.

PMID:
20182200
11.

[Girl with ptosis, anisocoria and hemiparesis].

Uyttenboogaart M, Postma AG.

Ned Tijdschr Geneeskd. 2012;156(5):A2960. Dutch.

PMID:
22296889
12.

False negative apraclonidine test in two patients with Horner syndrome.

Kawasaki A, Borruat FX.

Klin Monbl Augenheilkd. 2008 May;225(5):520-2. doi: 10.1055/s-2008-1027349.

PMID:
18454417
13.

Horner syndrome in fibromuscular dysplasia without carotid dissection.

McInnis CP, Haynor DR, Francis CE.

Can J Ophthalmol. 2016 Apr;51(2):e53-5. doi: 10.1016/j.jcjo.2015.10.019. No abstract available.

PMID:
27085276
14.

Effect of 0.5% apraclonidine on ptosis in Horner syndrome.

Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL.

Ophthal Plast Reconstr Surg. 2006 Jan-Feb;22(1):53-5.

PMID:
16418668
15.

The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.

Bacal DA, Levy SR.

Arch Ophthalmol. 2004 Feb;122(2):276-9. No abstract available.

PMID:
14769608
16.

The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.

Brown SM.

Arch Ophthalmol. 2005 Apr;123(4):578; author reply 578. No abstract available.

PMID:
15824244
17.

The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.

Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E.

Br J Ophthalmol. 2005 Nov;89(11):1442-4.

18.

Acquired infantile Horner syndrome and spontaneous internal carotid artery dissection: a case report and review of literature.

Pirouzian A, Holz HA, Ip KC, Sudesh R.

J AAPOS. 2010 Apr;14(2):172-4. doi: 10.1016/j.jaapos.2009.12.169. Review.

PMID:
20451860
19.

Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.

Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.

Am J Ophthalmol. 2006 Sep;142(3):469-74.

PMID:
16935593
20.

Sudden-onset anisocoria in a patient with upper respiratory tract infection.

Furlan JC, Sundaram AN.

CMAJ. 2014 Jan 7;186(1):57-61. doi: 10.1503/cmaj.130581. Epub 2013 Nov 11. No abstract available.

Supplemental Content

Support Center